# Personalis, Inc. (PSNL) FY2026 YTD Q2 P&L / Income Statement

- Company: Personalis, Inc. (PSNL)
- Period: 2026-01-01 to 2026-06-30
- Filing: Q2 FY2026 10-Q, filed 2026-08-04, accession number 0001193125-26-332817
- Page: https://plicit.ai/financials/psnl/fy2026-ytd-q2-income-statement
- Chart image: https://plicit.ai/charts/psnl-fy2026-ytd-q2-income-statement-sankey.png

## Chart details: Revenue by Major Customers

Income statement for 2026-01-01 through 2026-06-30. View: Major Customers. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Revenue**: 37,829,000 US dollars
- **Cost of revenue**: 32,805,000 US dollars
- **Gross profit (calculated)**: 5,024,000 US dollars
- **Operating expenses (calculated)**: 70,776,000 US dollars
- **Loss from operations**: negative 65,752,000 US dollars
- **Other income (expense), net (calculated)**: 4,058,000 US dollars
- **Loss before income taxes**: negative 61,694,000 US dollars
- **Provision for income taxes**: 21,000 US dollars
- **Net loss**: negative 61,715,000 US dollars
- **Pharma Testing Services**: 27,513,000 US dollars
- **Enterprise Sales**: 393,000 US dollars
- **Population Sequencing**: 5,500,000 US dollars
- **Clinical diagnostic**: 3,972,000 US dollars
- **Other**: 451,000 US dollars
- **Research and development**: 30,875,000 US dollars
- **Selling, general and administrative**: 39,901,000 US dollars

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.